SOLENO THERAPEUTICS INC (SLNO)

Investors Snatch SLNO Even Lower Than Its Secondary Stock Offering

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock

REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage...

Soleno Therapeutics Announces Proposed Public Offering of Common Stock

REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), (

Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome

Statistically Significant Improvements with DCCR Compared to Natural History of PWS from the PATH for PWS Study in Hyperphagia and PWS-related Behaviors...

Monday Sector Leaders: Television & Radio, Drugs

Why Soleno Therapeutics Stock Is Skyrocketing Today

The clinical-stage biotech company received great news from the FDA.

The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.

These stocks are gapping in today's session

Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)

First Ever Breakthrough Designation for a Drug Being Developed for PWS Designation is Based on Data from the Phase 3 Program for DCCR Planned...

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q4 2023

SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

SLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Soleno Therapeutics (NASDAQ:SLNO) just reported results for the fourth quarter ...

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

REDWOOD CITY, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

First Week of February 16th Options Trading For Soleno Therapeutics (SLNO)

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

Soleno Therapeutics Strengthens Leadership Team with Key Appointments

REDWOOD CITY, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

Watch out above - these highly-shorted stocks are pushing higher

A number of highly-shorted consumer sector stocks, including Fisker and Spirit Airlines, are seeing gains on Monday due to various factors such as deals and...

Shorts are feeling the heat on these ten stocks

Discover which stocks may potentially see a short squeeze based on their stock borrow rates and short interest over $25 million, including VinFast Auto,...

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

Soleno Therapeutics files for automatic mixed securities shelf offering (NASDAQ:SLNO)

Soleno Therapeutics files preliminary prospectus for automatic mixed securities shelf offering.

Why Soleno Therapeutics Stock Ticked Higher on Thursday

The latest pundit take on the stock provided a good reason for bulls to snap it up.

Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023

These three stocks to take profits on rallied more than 200% this year. Those gains are exceedingly unlikely to repeat in 2024.

Take Profit: 3 Stocks to Sell That Are Up More Than 200% in 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The stock market is ending 2023 with outsized gains. Investors are in a cheerfu...

3 Stock Winners That Are Up 500% or More in 2023

If you want to find 2023's top-performing stock, check out these companies that returned 500% or more since January

7 Stock Winners That Are Up 1,000% or More in 2023

Could any or all of these seven stocks up 1000% this year go on another hot run during 2024? Let's find out.

5 ‘Jackpot’ Stocks to Buy for 2024 for 10X Gains

These stocks to buy have the potential to take your portfolio to the next level thanks to the cutting-edge technology they represent.

Feeling Lucky? 5 ‘Jackpot’ Stocks to Buy for 2024.

When investors land on a "jackpot" stock, gains can offset even the steepest losses. Here are the top stocks to buy if you're feeling lucky.

3 Biotech Stocks With Big-Time Breakthrough Potential

The biotech industry is filled with opportunity with these sure winners, pick up high-potential stocks like these and ride the wave.

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

Soleno files to sell 3M shares of common stock for holders (NASDAQ:SLNO)

Soleno Therapeutics (SLNO) files a prospectus for the selling of up to 3M shares of its common stock.

The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA

Some big 2023 winners are shorted heavily, including two AI plays.

Correcting & Replacing -- Soleno Therapeutics Announces DCCR Data Presentation at the Foundation for Prader-Willi Research Symposium

In a press release issued earlier this afternoon, the time zone of the FPWR Research Symposium presentation was labeled as Central Time. The correct time...